AU3897585A - Etoposide composition - Google Patents

Etoposide composition

Info

Publication number
AU3897585A
AU3897585A AU38975/85A AU3897585A AU3897585A AU 3897585 A AU3897585 A AU 3897585A AU 38975/85 A AU38975/85 A AU 38975/85A AU 3897585 A AU3897585 A AU 3897585A AU 3897585 A AU3897585 A AU 3897585A
Authority
AU
Australia
Prior art keywords
etoposide
composition
etoposide composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU38975/85A
Other versions
AU571308B2 (en
Inventor
Selima Begum
Bernard C. Nunning
Ismat Ullah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU3897585A publication Critical patent/AU3897585A/en
Application granted granted Critical
Publication of AU571308B2 publication Critical patent/AU571308B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU38975/85A 1984-03-19 1985-02-20 Etoposide composition Ceased AU571308B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19
US591144 1984-03-19

Publications (2)

Publication Number Publication Date
AU3897585A true AU3897585A (en) 1985-09-26
AU571308B2 AU571308B2 (en) 1988-04-14

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38975/85A Ceased AU571308B2 (en) 1984-03-19 1985-02-20 Etoposide composition

Country Status (28)

Country Link
JP (1) JPS60209516A (en)
KR (1) KR850006136A (en)
AT (1) AT392904B (en)
AU (1) AU571308B2 (en)
BE (1) BE901963A (en)
CA (1) CA1238578A (en)
CH (1) CH662731A5 (en)
DE (1) DE3509741A1 (en)
DK (1) DK164535C (en)
EG (1) EG17521A (en)
ES (1) ES8702140A1 (en)
FI (1) FI84023C (en)
FR (1) FR2561104B1 (en)
GB (1) GB2155789B (en)
GR (1) GR850688B (en)
IE (1) IE58340B1 (en)
IL (1) IL74615A (en)
IT (1) IT1187640B (en)
LU (1) LU85812A1 (en)
MY (1) MY101916A (en)
NL (1) NL8500739A (en)
NO (1) NO170569C (en)
NZ (1) NZ211078A (en)
OA (1) OA07968A (en)
PT (1) PT80131B (en)
SE (1) SE8501312L (en)
YU (1) YU45243B (en)
ZA (1) ZA851935B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU573339B2 (en) * 1984-05-15 1988-06-02 Nippon Kayaku Kabushiki Kaisha Gelatin capsule containing etoposide
AU583585B2 (en) * 1985-02-19 1989-05-04 Nippon Kayaku Kabushiki Kaisha Etoposide preparations

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3629386A1 (en) * 1986-08-29 1988-03-03 Scherer Gmbh R P GELATINE CAPSULES AND METHOD FOR THEIR PRODUCTION
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (en) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc Absorption promoter for large intestine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (en) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (en) * 1974-11-07 1976-05-13 Universal Oil Prod Co Engine crankcase gases treatment - by catalytic reactor in heat exchange and partial mixture with exhaust gases
FR2358144A1 (en) * 1976-07-13 1978-02-10 Lipha Compsn. for treating biliary lithiasis - contains hymecromone and chenodeoxy-cholic acid, with lower cost and better tolerance
JPS5940137B2 (en) * 1976-10-14 1984-09-28 武田薬品工業株式会社 Pharmaceutical composition for oral administration
FR2410504A1 (en) * 1977-12-05 1979-06-29 Air Liquide Safety control in chemical reactor carrying out oxidations - comprises oxygen concn. monitoring in gaseous phase and nitrogen injections if set concn. is reached
DE2809543A1 (en) * 1978-03-06 1979-09-13 Werner Henke Rendering oil or gas well gases harmless - by desulphurisation and oxidn. in catalytic reactors
JPS60239418A (en) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd Soft capsule containing etoposide

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU573339B2 (en) * 1984-05-15 1988-06-02 Nippon Kayaku Kabushiki Kaisha Gelatin capsule containing etoposide
AU583585B2 (en) * 1985-02-19 1989-05-04 Nippon Kayaku Kabushiki Kaisha Etoposide preparations

Also Published As

Publication number Publication date
EG17521A (en) 1990-06-30
FI851040L (en) 1985-09-20
YU45243B (en) 1992-05-28
OA07968A (en) 1987-01-31
FR2561104B1 (en) 1988-04-08
CA1238578A (en) 1988-06-28
GB8506943D0 (en) 1985-04-24
BE901963A (en) 1985-09-18
NO170569C (en) 1992-11-04
IL74615A (en) 1988-07-31
FI84023C (en) 1991-10-10
ATA81985A (en) 1990-12-15
DE3509741A1 (en) 1985-09-26
AT392904B (en) 1991-07-10
PT80131A (en) 1985-04-01
ES541370A0 (en) 1986-12-16
JPS60209516A (en) 1985-10-22
GB2155789A (en) 1985-10-02
ZA851935B (en) 1985-10-30
DK122285D0 (en) 1985-03-18
NZ211078A (en) 1987-08-31
KR850006136A (en) 1985-10-02
NL8500739A (en) 1985-10-16
SE8501312L (en) 1985-09-20
LU85812A1 (en) 1985-12-12
DK122285A (en) 1985-09-20
ES8702140A1 (en) 1986-12-16
IL74615A0 (en) 1985-06-30
FI851040A0 (en) 1985-03-15
GB2155789B (en) 1987-10-21
IE850686L (en) 1985-09-19
MY101916A (en) 1992-02-15
IE58340B1 (en) 1993-09-08
NO170569B (en) 1992-07-27
PT80131B (en) 1987-10-20
YU42085A (en) 1988-02-29
GR850688B (en) 1985-07-08
DK164535B (en) 1992-07-13
IT1187640B (en) 1987-12-23
DK164535C (en) 1992-11-30
CH662731A5 (en) 1987-10-30
IT8519897A0 (en) 1985-03-14
NO851022L (en) 1985-09-20
FR2561104A1 (en) 1985-09-20
AU571308B2 (en) 1988-04-14
FI84023B (en) 1991-06-28
SE8501312D0 (en) 1985-03-18

Similar Documents

Publication Publication Date Title
AU4222285A (en) Pyrrolobenzimidazoles
AU3839785A (en) Sammelpackung
AU4254685A (en) Arylhydroxamates
AU4256585A (en) 1-heteroaryl-4-aryl-pyrazolin-5-ones
AU3749685A (en) Induktionsmotor
AU4105285A (en) Tetrahydrofuran-2-ylmethylamines
AU4061285A (en) Schaltersicherungseinheit
AU584104B2 (en) Novel isoindolinyl-alkyl-piperazines
AU590229B2 (en) Novel homopropargylamines
AU4118385A (en) Verbindungselement
AU574452B2 (en) Substituted dienamides
AU571308B2 (en) Etoposide composition
AU581673B2 (en) Substituted 7-oxomitosanes
AU583063B2 (en) Novel compounds
AU4274285A (en) Cycloalkane-indene-carboximidamides
AU4271085A (en) Metallophosphoaluminates
AU4665585A (en) Substituted arylsulphonylguanidines
AU4694485A (en) Substituted phenylsulfonylazones
AU4061585A (en) Automatisk fadolsaftapningsanlaeg
AU4216685A (en) Aminocarnitines
AU4200785A (en) Diamino - 6 - halogeno - 5 - alkylthio-pyrimidines
AU3884285A (en) Heibmangel
AU4163585A (en) Benzothiopyranones
AU4271185A (en) Ferrophosphoaluminates
AU4254785A (en) Tetrahydronaphthalenols